Table 4

Estimated total direct and indirect costs per patient over 5 years

HER2−/HR+HER2+/HR+HER2+/HR−Triple negativeAverage
Direct costs
 Active treatment20 366 €150 131 €147 784 €26 506 €58 664 €
 Toxicity management1251 €1725 €1703 €1873 €1492 €
 Diagnostic2546 €2562 €2545 €2433 €2529 €
 Medical follow-up18 678 €24 444 €22 578 €14 163 €19 361 €
 Palliative/BSC costs77 595 €111 167 €74 276 €49 434 €78 359 €
 Total direct costs1 204 376 €290 029 €248 885 €94 409 €160 405 €
 Indirect costs227 €317 €266 €164 €237 €
 Total direct and indirect costs120 664 €290 346 €249 152 €94 572 €160 642 €
  • BSC, best supportive care; HER2, human epidermal growth factor receptor 2; HR, hormonal receptor.